These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2256314)

  • 1. [A trial of a cultured inactivated vaccine against hepatitis A on Saguinus mystax tamarins].
    Poleshchuk VF; Balaian MS; Sobol' AV; Titova IP; Guliaeva TV; Dokin VP; Kusov IuIu
    Vopr Virusol; 1990; 35(4):296-9. PubMed ID: 2256314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunogenicity of a cultured inactivated hepatitis A vaccine].
    Kusov IuIu; El'bert LB; Kazachkov IuA; Val'iano NM; Nel'ga IV; Grishina GK; Krutianskaia GL; Lisitsyna EA; Poleshchuk VF; Sobol' AV
    Vopr Virusol; 1991; 36(3):206-9. PubMed ID: 1654007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A trial of a hepatitis A cultured inactivated vaccine on rhesus macaques].
    Shevtsova ZV; Flehmig B; Lapin BA; Esvandzhiia NCh; Krylova RI; Dzhelieva ZN; Tsyganok NM
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):55-9. PubMed ID: 7653138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets.
    D'Hondt E; Purcell RH; Emerson SU; Wong DC; Shapiro M; Govindarajan S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S40-3. PubMed ID: 7876647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The specific safety of a cultured inactivated vaccine against hepatitis A].
    Kusov IuIu; Orlova TM; Panina LI; Kazachkov IuA; Nel'ga IV; El'bert LB; Krutianskaia GL; Poleshchuk VF; Sobol' AV; Titova IP
    Vopr Virusol; 1991; 36(2):156-9. PubMed ID: 1652870
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of immunogenicity and safety in healthy adults of an inactivated anti-hepatitis A vaccine].
    Gil A; González A; Dal-Ré ; Aguilar L; Malo C; del Rey J
    Med Clin (Barc); 1994 May; 102(20):769-71. PubMed ID: 8041214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The modelling of hepatitis A and of enterally transmitted non-A, non-B hepatitis (hepatitis E) in Saguinus mystax tamarins].
    Poleshchuk VF; Balaian MS; Andzhaparidze AG; Sobol' AV; Dokin VP; Guliaeva TV; Titova IP
    Vopr Virusol; 1990; 35(5):379-82. PubMed ID: 1967121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against hepatitis A by an inactivated vaccine.
    Innis BL; Snitbhan R; Kunasol P; Laorakpongse T; Poopatanakool W; Kozik CA; Suntayakorn S; Suknuntapong T; Safary A; Tang DB
    JAMA; 1994 May; 271(17):1328-34. PubMed ID: 8158817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of inactivated hepatitis A vaccine in children.
    Lee SD; Lo KJ; Chan CY; Yu MY; Wang YJ; Safary A
    Gastroenterology; 1993 Apr; 104(4):1129-32. PubMed ID: 8462802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers.
    Wagner G; Lavanchy D; Darioli R; Pécoud A; Brulein V; Safary A; Frei PC
    Vaccine; 1993; 11(10):1027-32. PubMed ID: 8212822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
    Chlibek R; Smetana J; Bostíková V; Splino M
    Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
    Guan R; Ng HS; Fock KM; Ho KY; Yap I; Kang JY; Chow WC; Chew CN; Ng C; Teo CJ
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):268-71. PubMed ID: 8629058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more.
    Scheifele DW; Bjornson GJ
    CMAJ; 1993 Feb; 148(4):551-5. PubMed ID: 8431816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protracted alanine aminotransferase levels in tamarins infected with hepatitis A virus.
    Karayiannis P; Chitranukroh R; Fry M; Petrovic LM; Moore D; Scheuer PJ; Thomas HC
    J Med Virol; 1990 Feb; 30(2):151-8. PubMed ID: 2156008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.
    Vimolket T; Theamboonlers A; Dumas R; Milcamps B; Forrat R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):779-85. PubMed ID: 10772564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.